The US Special Operations Forces Command (SOCOM) plans to conduct clinical trials of an oral anti-aging drug next year, Breaking Defense reported, citing service officials.

The command has spent $2.8 million in a joint effort with a private biotech laboratory, Metro International Biotech, LLC (MetroBiotech), since 2018 to develop the pill. 

Read the full article at www.thedefensepost.com